This review discusses the evidence supporting the use of oral alitretinoin (the active component of Zematane®) in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids. Oral alitretinoin is the only systemic medicine specifically approved for the treatment of hand eczema. This review is sponsored by an educational grant from Douglas Pharmaceuticals Ltd.
Please login below to download this issue (PDF)